Blue Capital Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.73M Sell
3,107
-511
-14% -$522K 2.37% 5
2026
Q1
$3.33M Buy
3,618
+109
+3% +$111K 2.17% 10
2025
Q4
$3.77M Buy
3,509
+4
+0.1% +$3.83K 2.69% 7
2025
Q3
$2.67M Sell
3,505
-374
-10% -$278K 1.99% 14
2025
Q2
$3.02M Buy
+3,879
New +$3.01M 2.14% 11
2024
Q4
$3.09M Buy
+4,000
New +$3.31M 2.18% 16

Other funds holding LLY

Blue Capital Inc's LLY Position: Q2 2026 in Review

Blue Capital Inc reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $522K and leaving 3,107 shares worth $3.73M. The position accounts for 2.37% of the portfolio, ranked #5.

Blue Capital Inc first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.77M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blue Capital Inc held 3,107 shares of Eli Lilly worth $3.73M as of Q2 2026.
  • Blue Capital Inc sold 511 Eli Lilly shares in Q2 2026, an estimated $522K.
  • Eli Lilly made up 2.37% of Blue Capital Inc's portfolio in Q2 2026, its #5 holding.
  • Blue Capital Inc first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Blue Capital Inc's Eli Lilly position peaked at $3.77M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blue Capital Inc's 13F filing for Q2 2026, filed 11 Aug 2026.